Exact Sciences Corp.

EXAS

$93.98

-3.4% (1 year change)

Market Cap

$16.5 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$89.65 - $159.54

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-19.13x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $16.5 Billion
Enterprise Value $17.4 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return -3.4%
52-Week High $159.54
52-Week Low $89.65
Beta 0.78
Outstanding Shares 172 Million
Avg 30 Day Volume 1.34 Million

Valuation

P/E Ratio -19.13
PEG -18.15
Earnings per Share -$5.34
Price to Sales Ratio 10.44
Price to Book Ratio 4.7
Revenue to Enterprise Value 10.19
EBIT to Enterprise Value -19.79
Total Debt to Enterprise Value 0.13
Debt to Equity 0.62

Profitability

Revenue $1.71 Billion
Gross Profit $1.29 Billion
EBIT -$881 Million
Net Income -$865 Million
Profit Margin -50.52%
Quarterly Earnings Growth (YoY) +105.4%
Return on Equity -24.3%
Return on Assets -12.86%
Return on Invested Capital -14.57%

Insider trades

No purchases

204,580 shares sold (29 transactions)

No purchases

54,379 shares sold (3 transactions)

No purchases

52,001 shares sold (6 transactions)

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Exact Sciences Corp.

CEO: Kevin Conroy

Industry: Research and Development in Biotechnology

Similar stocks

Myriad Genetics, Inc.
Invacare Corp.
Antares Pharma Inc
Veracyte Inc
Biocept Inc
Sanofi - ADR

News

Zacks: Brokerages Expect Exact Sciences Co. (NASDAQ:EXAS) Will Announce Quarterly Sales of $429.04 Million

Zacks: Brokerages Expect Exact Sciences Co. (NASDAQ:EXAS) Will Announce Quarterly Sales of $429.04 Million

Equities research analysts expect Exact Sciences Co. (NASDAQ:EXAS) to announce $429.04 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Exact S...

 Dakota Financial News Dakota Financial News, about 20 hours ago
Blood tests that can detect cancer are about to hit the market. But experts are still waiting to see if they can upend deadly disease.

Blood tests that can detect cancer are about to hit the market. But experts are still waiting to see if they can upend deadly disease.

Two blood tests made by Exact Sciences and Illumina that aim to pinpoint early signs of cancer are launching in the US.

Business Insider Business Insider, 4 days ago
Should I Avoid EXACT Sciences Corporation (EXAS)?

Should I Avoid EXACT Sciences Corporation (EXAS)?

No summary available.

Insider Monkey Insider Monkey, 12 days ago